SMOC2 promotes peritoneal metastasis of gastric cancer involving Wnt/β-catenin pathway modulation and inducing angiogenesis

Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide, with peritoneal metastasis commonly seen in advanced cases. Based on RNA-sequencing data from GEO dataset, we focused on the role of SMOC2, SPARC-related modular calcium-binding protein 2, in regulating GC progression and peritoneal metastasis. Our analysis revealed that high SMOC2 expression was associated with poor survival in the population with peritoneal metastases. Functional assays demonstrated that SMOC2 promotes the migration and invasion of GC cells in vitro. In vivo experiments using a mouse peritoneal metastasis model showed that SMOC2 promoted the peritoneal metastasis of GC cells. Additionally, in a co-culture system of GC cells and endothelial cells, SMOC2 overexpression in GC cells promoted the proliferation, migration, and tube formation capability of endothelial cells. Mechanistically, SMOC2 knockdown reduced GSK-3β phosphorylation and nuclear β-catenin levels, accompanied by decreased expression of downstream target genes. These results indicate that SMOC2 promotes GC peritoneal metastasis involving Wnt/β-catenin pathway modulation. In conclusion, our findings highlight SMOC2's significant role in GC progression, potentially involving Wnt/β-catenin pathway modulation and angiogenesis. These results position SMOC2 as a potential prognostic biomarker and therapeutic target for GC peritoneal metastasis.

• Publication year

  2025

• Venue

  Clinical and Experimental Medicine (Testo stampato)

• Publication date

  2025-11-11

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s10238-025-01914-6PMCID 12605374
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhanced Expression of TRIM46 in Ovarian Cancer Cells Induced by Tumor-Associated Macrophages Promotes Invasion via the Wnt/β-Catenin Pathway

  2025cited by this paper
• Single‐cell characterization of differentiation trajectories and drug resistance features in gastric cancer with peritoneal metastasis

  2024cited by this paper
• Wnt signaling in gastric cancer: current progress and future prospects

  2024cited by this paper
• SPI1+CD68+ macrophages as a biomarker for gastric cancer metastasis: a rationale for combined antiangiogenic and immunotherapy strategies

  2024cited by this paper
• Histone Deacetylase 2 Stabilizes SPARC-related Modular Calcium Binding 2 to Promote Metastasis and Stemness in Gallbladder Cancer.

  2024cited by this paper
• ESM1 Interacts with c-Met to Promote Gastric Cancer Peritoneal Metastasis by Inducing Angiogenesis

  2023cited by this paper
• Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis

  2023cited by this paper
• The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future

  2022cited by this paper
• Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

  2022cited by this paper
• SMOC2 promotes an epithelial-mesenchymal transition and a pro-metastatic phenotype in epithelial cells of renal cell carcinoma origin

  2022cited by this paper
• Clinical epidemiology of peritoneal metastases in China: The construction of professional peritoneal metastases treatment centers based on the prevalence rate.

  2022cited by this paper
• MicroRNA-19a-3p Acts as an Oncogene in Gastric Cancer and Exerts the Effect by Targeting SMOC2

  2022cited by this paper
• Cancer Statistics, 2021

  2021cited by this paper
• Circular RNA circSmoc1-2 regulates vascular calcification by acting as a miR-874-3p sponge in vascular smooth muscle cells

  2021cited by this paper
• Targeting ADAR1 suppresses progression and peritoneal metastasis of gastric cancer through Wnt / β-catenin pathway

  2021cited by this paper
• Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C/EBPβ-mediated PDGFB autocrine and paracrine signaling

  2021cited by this paper
• The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer

  2021cited by this paper
• SPARC-related modular calcium binding 1 regulates aortic valve calcification by disrupting BMPR-II/p-p38 signalling

  2021cited by this paper
• Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer

  2020cited by this paper
• Zic1 suppresses gastric cancer metastasis by regulating Wnt/β‐catenin signaling and epithelial‐mesenchymal transition

  2020cited by this paper
• Downregulation of SMOC2 expression in papillary thyroid carcinoma and its prognostic significance

  2020cited by this paper
• Omental adipocytes promote peritoneal metastasis of gastric cancer through the CXCL2–VEGFA axis

  2020cited by this paper
• SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers

  2020cited by this paper
• Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma

  2018cited by this paper
• Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative Therapy

  2017cited by this paper
• Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression

  2016cited by this paper
• Molecular mechanisms of peritoneal dissemination in gastric cancer.

  2016cited by this paper
• Smoc2 potentiates proliferation of hepatocellular carcinoma cells via promotion of cell cycle progression

  2016cited by this paper
• ZnPPIX inhibits peritoneal metastasis of gastric cancer via its antiangiogenic activity.

  2015cited by this paper
• Peritoneal carcinomatosis of gastric origin: A population‐based study on incidence, survival and risk factors

  2014cited by this paper
• Management of gastric cancer in Asia: resource-stratified guidelines.

  2013cited by this paper
• Tumor angiogenesis: molecular pathways and therapeutic targets

  2011cited by this paper
• Mutations in the SPARC-related modular calcium-binding protein 1 gene, SMOC1, cause waardenburg anophthalmia syndrome.

  2011cited by this paper
• Mechanisms of lung development: contribution to adult lung disease and relevance to chronic obstructive pulmonary disease.

  2009cited by this paper
• The widely expressed extracellular matrix protein SMOC-2 promotes keratinocyte attachment and migration.

  2008cited by this paper
• Wnt signaling: complexity at the surface

  2006cited by this paper
• The Novel SPARC Family Member SMOC-2 Potentiates Angiogenic Growth Factor Activity*

  2006cited by this paper
• VEGF significance in peritoneal recurrence from gastric cancer

  2005cited by this paper
• Deregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferation.

  2005cited by this paper
• Characterization of SMOC-2, a modular extracellular calcium-binding protein.

  2003cited by this paper

• No citing papers are available for this paper.